Jeff Keyes

Chief Financial Officer

Jeff brings over 25 years of experience leading finance teams for both privately held and publicly traded companies, including an array of life sciences companies. Prior to Spinal Elements, Mr. Keyes spent 4 years as the Chief Financial Officer of Custopharm, Inc., a private equity backed developer of generic sterile injectable pharmaceuticals that was successfully acquired by Hikma Pharmaceuticals. In the 6 years prior to CustomPharm, Mr. Keyes served as Chief Financial Officer and Corporate Secretary of Digirad Corporation, a publicly traded healthcare services and medical device company. In 2011 and 2012, Mr. Keyes was the Corporate Controller of Sapphire Energy, Inc., a venture capital backed start-up life sciences company focused on renewable energy and the Corporate Controller of Advanced BioHealing, Inc., a venture backed provider of regenerative medicine solutions that was successfully acquired by Shire, PLC in August 2011. Prior to 2011, Mr. Keyes held a variety of leadership roles in healthcare and medical device companies in finance, accounting, and M&A support, and he started his career in public accounting. Mr. Keyes earned a B.A. degree in accounting from Western Washington University and is a certified public accountant.

Tomorrow’s spinal surgery solutions start here.

Learn more about how advanced, minimally invasive
surgical solutions from Spinal Elements are transforming
treatment and improving patient outcomes.